View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

IZEA Announces Q3 2025 Earnings Results Conference Call

IZEA Announces Q3 2025 Earnings Results Conference Call ORLANDO, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ), a leading influencer marketing company that makes Creator Economy solutions for marketers, announced today that its conference call to review and discuss its third quarter 2025 financial results will begin at 5:00 p.m. Eastern Standard Time on November 12, 2025. IZEA’s Chief Executive Officer Patrick Venetucci and Chief Financial Officer Peter Biere will host the call, followed by a question and answer period. Date: Wednesday, November 12, 2025 Time: 5:00 p.m. EST Webc...

 PRESS RELEASE

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Participate in Upcoming Investor Conferences WAYNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences: Guggenheim Second Annual Healthcare Innovation ConferenceFireside ChatNovember 10, 2025, at 4:00 pm ET Stifel 2025 Healthcare ConferenceFireside ChatNovember 12, 2025, at 2:40 pm ET TD Cowen 1st Immunology & Inflamm...

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: November 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: November 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: October 31, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

ViaSat-3 F2 Satellite Confirmed to Launch November 5, 2025

ViaSat-3 F2 Satellite Confirmed to Launch November 5, 2025 Expected to more than double Viasat’s current network capacity, ViaSat-3 F2 is designed to fuel customer growth, supporting next-generation connectivity platforms such as Viasat Amara, NexusWave, and Government Hybrid SATCOM Architecture CARLSBAD, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: VSAT), a global leader in satellite communications, today confirmed the scheduled launch date of its ViaSat-3 F2 satellite is November 5, 2025, during a window opening at 10:24PM ET. The satellite will be launched aboard a United Lau...

 PRESS RELEASE

Viasat Sets November 7, 2025 for Second Quarter Fiscal Year 2026 Finan...

Viasat Sets November 7, 2025 for Second Quarter Fiscal Year 2026 Financial Results Conference Call and Webcast CARLSBAD, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: VSAT), a global leader in satellite communications, today announced it will release its second quarter fiscal year 2026 financial results on Friday, November 7, 2025 after the market closes, via a letter to shareholders posted to the  section of its website. The Company will also host a conference call and webcast on Friday, November 7, 2025 at 2:30 p.m. Pacific Time / 5:30 p.m. Eastern Time. To participate on the li...

 PRESS RELEASE

OPKO Health Reports Third Quarter 2025 Business Highlights and Financi...

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights from the third quarter of 2025 and recent weeks include the following: Entered into a research collaboration with Regeneron Pharmaceuticals to develop multispecific antibodies. This new partnership leverages ModeX’s MSTAR technology platform with Regeneron’s...

 PRESS RELEASE

OPKO Health’s ModeX Therapeutics Enters into Research Collaboration wi...

OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if multiple assets advance WESTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that it has entered into a license and collaboration agreement with Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) to discover and develop multi...

 PRESS RELEASE

Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS...

Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that the Company has completed enrollment in its Phase 2 LOTUS trial of AVTX-009 in adults with hidradenitis suppurativa (HS). The LOTUS trial exceeded target enrollment of 222 patients with approximately 250 patients enro...

 PRESS RELEASE

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for ...

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein  Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced the initiation and recent dosing of the first patient in a Phase 1/2a clinical trial () with MDX2004, a first-in-class trispecific antibody-fusion protein for oncology...

 PRESS RELEASE

OPKO Health to Report Third Quarter 2025 Financial Results on October ...

OPKO Health to Report Third Quarter 2025 Financial Results on October 29 MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial markets on Wednesday, October 29, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on October 29th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages parti...

 PRESS RELEASE

Viasat Demonstrates First Satellite SMS Messages on Android Smartphone...

Viasat Demonstrates First Satellite SMS Messages on Android Smartphone in Mexico At an event held in Mexico City, the operator showcased direct-to-device (D2D) connectivity in action, including native SMS messages and push-to-talk via satellite on a commercially available Android smartphone MEXICO CITY, Oct. 16, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: VSAT), a global leader in satellite communications, has completed an-in-country first-of-its-kind direct-to-device (D2D) demonstration in Mexico – featuring native Short Message Service (SMS) messages on the Android smartphone. The demonstrati...

 PRESS RELEASE

Viasat Awarded Contract by U.S. Space Force for Protected Tactical SAT...

Viasat Awarded Contract by U.S. Space Force for Protected Tactical SATCOM-Global (PTS-G) Program Viasat was selected for an initial design award under the larger Indefinite Delivery Indefinite Quantity (IDIQ) contract for future anti-jam satellites CARLSBAD, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: VSAT), a global leader in satellite communications, today announced it has been selected for a prime contract award by the U.S. Space Force (USSF) Space Systems Command (USSF SSC) for the Protected Tactical SATCOM-Global (PTS-G) program. under what is a large Indefinite Delivery In...

 PRESS RELEASE

Avalo Therapeutics Expands Leadership Team with Key Appointments in Bu...

Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources WAYNE, Pa., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced the expansion of its leadership team with two senior appointments: Taylor Boyd has been named Chief Business Officer, and Ashley Ivanowicz has joined as Senior Vice President, Human Resources. “We are delighted to welcome Taylor and Ashley to Aval...

 PRESS RELEASE

Space42 and Viasat to Launch Equatys Venture with Access to World’s La...

Space42 and Viasat to Launch Equatys Venture with Access to World’s Largest Coordinated Spectrum Block for Global Direct to Device Services Enables global delivery of D2D services wherever terrestrial networks are not availableCreates industry-first space tower company model, implementing shared space and ground Non-Terrestrial-Network (NTN) infrastructure, lowering capital costs and improving spectrum utilization for all participantsFacilitates evolution of existing Mobile Satellite Services to a 5G network environment PARIS, Sept. 15, 2025 (GLOBE NEWSWIRE) -- (ADX: SPACE42), the UAE-b...

 PRESS RELEASE

Viasat Announces ViaSat-3 F2 Scheduled to Launch in October, Expected ...

Viasat Announces ViaSat-3 F2 Scheduled to Launch in October, Expected to More Than Double Viasat’s Bandwidth Capacity ViaSat-3 F2 dynamic beam forming capabilities will deliver extensive benefits to customers in the highest demand places, with anticipated service entry in early 2026 Viasat’s ultra-high-capacity constellation is designed to meet the increasing demand for resilient, global satellite communications from commercial mobility and defense customers CARLSBAD, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: VSAT), a global leader in satellite communications, tod...

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: September 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Participate in Upcoming Investor Conferences WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences: Cantor Global Healthcare ConferenceFireside ChatSeptember 3, 2025, at 2:10 pm ET H.C.Wainwright 27th Annual Global Investment ConferencePresentationSeptember 9, 2025, at 2:30 pm ET Stifel 2025 Virtual Immunology and...

 PRESS RELEASE

Australia and New Zealand Expand SouthPAN Program with Viasat through ...

Australia and New Zealand Expand SouthPAN Program with Viasat through $252m AUD Award for Additional Satellite Services Geoscience Australia and Toitū Te Whenua Land Information New Zealand have expanded the agreement with Viasat for the world class satellite-based augmentation system, SouthPAN CARLSBAD, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced a $252 million AUD award from Geoscience Australia (GA) and Toitū Te Whenua Land Information New Zealand (LINZ) to deliver additional satellite services fo...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch